Massive Ivermectin study blows up false attacks on the drug, page-3

First 3 Last

Share
Profile

Follow
Newton999

2,604 Posts.

66

26/01/22

19:48

Post #: 59144186
Share

Originally posted by skint: ↑

They tested an entire city in Brazil over 5 months. 220,000 trial subjects The trial doctor has no doubt Ivermectin works. Low dose 2mg for 2 days once a fortnight as a prophylaxis against all strains. Safety data: 145,000 in the dose arm had no adverse effects. Dose response to IVM, the higher the dose = better kidney and liver serum level results. Dose dependent.
Compare to remdisavir, can damage kidneys and no real proof it works on omniron, approved.
Doc says 90% claim for PFE's Paxlovid in isolation not believable. Paxlovid has one of IVM MOA. IVM should be more effective. Paxlovid is protease inhibitor and works as direct antiviral. No data available to check.
IVM =73% reduction in hospitalization. Data on hospitalizations due in coming days. Data so far is posted on Cures website. Lowest mortality rate :40% below national average. Doc recommends IVM weekly. Works against omnicron. IVM has 20MOA's including protease inhibitor. Doc recommends using multiple therapeutics. Hydroxychloroquine, with zinc, is now back in play due to different cell entry method by omicron.
What to do when pulminory stage starts. He prevented his own mother from going to hospital with 90% of lung infected. 80mg of dexamethadone 5 days high dose IVM etc. Oxygen. In 3 days she was off oxygen. Remember we lost millions of lives to covid, but none through therapeutics.
Doc, "when we were needed to work as doctors with treatments for individual patients, we were prevented and 6 million deaths are the result"
Sorry above points were jotted down while listening to the broadcast. Significant numbers did not complete the study. Fact checkers predictably dispute findings.

Expand

Remdisavir is also known in hospitals as Run, death is Near
6 Upvote

Reply

Top Stories

ASX Market Open: Trump's unpause, RBA 'cut' call the clear Week 28 pacesetters | July 7

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

Trump chides Powell as Goldman call for calm. The RBA must be nervous

AII

Inside the depths of Panasqueira: A legacy carved in rock

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming